San Francisco, California, March 05, 2018 – The global medical foods market as anticipated in a report by TMR Research could attain growth with increasing focus on the development of disease-specific formulae for planning effective patient diet or nutrition care. Titled “Medical Foods Market – Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth and Forecast 2017 – 2025,” the report foresees high focus on the labeling and manufacturing of medical foods to work in the favor of the market. Furthermore, improving awareness about medical foods could bode well for market growth in the coming years. Medical foods are researched to complement certain treatments pretty well.
Get Sample Copy of this Report @
The world medical foods market is predicted to gain impetus due to its crucial role in disease management through the fulfillment of specific dietary requirements. Medical foods could also be used to overcome nutritional deficiencies, which is also one of the ways of managing a disease. Thus, increasing incidence of diseases such as attention deficit hyperactivity disorder (ADHD) in children and Alzheimer’s in adults could raise the demand for medical foods due to their application in the planning of specific diets. The healthcare industry could act as a fertile breeding ground for the market to expand its growth in the near future.
Since the geriatric population could be more susceptible to medical conditions that hamper their ability to absorb certain nutrients, any increase in its size is projected to magnify the need for medical foods. Geriatrics could be a substantial consumer group of the world medical foods market as nutrient deficiency disorders are more common among them. Diabetes could be one particular disease significantly augmenting the demand for medical foods. This is prophesied to be because of diabetic neuropathy being one of the vital applications of medical foods. As a result, rising prevalence of diabetes and swelling investments in the healthcare industry are prognosticated to set the tone for a valuable growth of the market.
The demand for medical foods could also ride on the growing incidence of neurodegenerative conditions among geriatrics. The role of medical foods in managing psychological disorders such as ADHD has also gained the spotlight due to extensive research to determine their causes and plan treatments. By mode of delivery, the international medical foods market is envisaged to witness a rising preference for pills over powders. This could be due to several patients observed to reject the taste of medical foods in powered form, although they could be easily mixed with other foods. Consequently, there has been a growing shift in preference toward pills.
On the regional front, the international medical foods market is envisioned to testify of the dominance of North America due to unhealthy lifestyles of people leading to diabetes and other diseases. The U.S. could be a crucial contributor to the North America market. Countries in North America have a detailed database of the dietary requirements of patients with different diseases. Moreover, the region enjoys a ready availability of forward-thinking healthcare technology.
In the near future, the international medical foods market is expected to benefit from a strong support for the development of advanced disease-specific formulae. Some of the prominent names of the industry are Primus Pharmaceuticals Inc., Danone, Targeted Medical Pharma Inc., Fresenius Kabi AG, and Abbott. The report provides important details about the companies profiled and also deeply studies the competitive landscape of the market.